Cytomegalovirus Clinical Trials Cytomegalovirus RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine
Condition:   Cytomegalovirus Infection Interventions:   Biological: mRNA-1647;   Biological: Placebo Sponsor:   ModernaTX, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 13, 2023 Category: Research Source Type: clinical trials